Incurred Sample Reproducibility: Views and Recommendations by the European Bioanalysis Forum
Year: 2009
Type: article
Source: Bioanalysis
DOI: 10.4155/bio.09.108
Authors: Philip Timmerman, Silke Luedtke, Peter van Amsterdam, Margarete Brudny-Kloeppel, Berthold Lausecker, Stephanie Fischmann, Susanne Globig, Carl-Johan Sennbro, Josep M Jansat, Hans Mulder, Elizabeth Thomas, Magnus Knutsson, Dirk Kasel, Stephen A White, Morten Anders Kall, Nathalie Mokrzycki-Issartel, Achim Freisleben, Fernando Romero, Michael Pilgård Andersen, Norbert Knebel, Marcel de Zwart, Sirpa Laakso, Richard S Hucker, Dietmar Schmidt, Ben Gordon, Richard Abbott, Pierre Boulanger
Institutions: Boehringer Ingelheim (Germany), Bayer (Germany), F. Hoffmann-La Roche AG, Abbott (United States), Active Biotech (Sweden), AstraZeneca (United Kingdom), Ferring Pharmaceuticals (Denmark), Grünenthal Group (Germany), Merck & Co., Inc., Rahway, NJ, USA (United States), Merck Serono S.A. (Switzerland), Novartis (Switzerland), Novo Nordisk (Denmark), Pfizer (United States), Sanofi (France), Servier (France), UCB Pharma (Belgium)
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2139470111